Clinical Trial Update: Mental Intervention and Nicotinamide Riboside Supplementation in Long Covid [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a mental intervention plus nicotinamide riboside supplementation for Long COVID; currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid

Drugs mentioned

• Nicotinamide Riboside (nicotinamide riboside)

Snippet

Sponsor: University Hospital, Akershus | Conditions: Long COVID | Phase 2 | Status: ACTIVE_NOT_RECRUITING